---
title: "Beta Bionics Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results"
description: "Beta Bionics Inc. will announce its fourth quarter and full year 2025 financial results on February 17, 2026, after market close. A conference call and webcast will follow at 4:30 pm ET to discuss the"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/272745659.md"
published_at: "2026-01-15T21:03:08.000Z"
---

# Beta Bionics Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results

> Beta Bionics Inc. will announce its fourth quarter and full year 2025 financial results on February 17, 2026, after market close. A conference call and webcast will follow at 4:30 pm ET to discuss the company's performance. The webcast can be accessed in the 'Investors-Events & Presentations' section.

Beta Bionics Inc. will release its fourth quarter and full year 2025 financial results after the financial markets close on Tuesday, February 17, 2026. Management will host a conference call and concurrent webcast to review the company’s performance on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time). The webcast will be available in the “Investors-Events & Presentations” section at here, and access to the live call by phone can be obtained at here Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9626008-en) on January 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [BBNX.US - Beta Bionics](https://longbridge.com/en/quote/BBNX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 10:53 ETINVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics | Faruqi & Faruqi, LLP is investigating potential claims against Beta Bionics (NASDAQ: BBNX) following a significant drop  | [Link](https://longbridge.com/en/news/275207402.md) |
| Beyond The Numbers: 4 Analysts Discuss Beta Bionics Stock | Analysts' ratings for Beta Bionics (NASDAQ:BBNX) show a mix of bullish and bearish sentiments. Recent evaluations indica | [Link](https://longbridge.com/en/news/273878747.md) |
| FDA Issues Warning Letter to Beta Bionics Over Quality System Deficiencies | Beta Bionics Inc. received a warning letter from the FDA due to deficiencies in its Quality Management System following  | [Link](https://longbridge.com/en/news/274358501.md) |
| Premium Valuation and Slowing New Patient Growth Drive Shift to Neutral on Beta Bionics | Travis Steed from Bank of America Securities downgraded Beta Bionics, Inc. to a Hold with a price target of $28.00, citi | [Link](https://longbridge.com/en/news/272057055.md) |
| Beta Bionics preliminary Q4 net sales rise | Beta Bionics reported preliminary Q4 net sales of $32 million, surpassing analyst expectations of $28.90 million. The DM | [Link](https://longbridge.com/en/news/271985385.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.